Scientific Review Clause Samples
The Scientific Review clause establishes a process for evaluating the scientific validity, methodology, and ethical considerations of a proposed research project or study. Typically, this involves submission of study protocols and related documents to a designated review board or committee, which assesses whether the research meets established standards and guidelines. By requiring this review, the clause ensures that research is conducted responsibly, protects participant welfare, and maintains compliance with regulatory or institutional requirements.
Scientific Review. The activities carried out by the EPA, NTP, and the NCGC in support of this MOU will be reviewed at regular intervals (initially, approximately every six months) by their respective review panels. For the NCGC, this is the NCGC Working Group, which reports to the NHGRI Board of Scientific Counselors. For the NTP and the EPA, this is their respective Boards of Scientific Counselors.
Scientific Review. Applications for a CIRM award that is in the form of a loan will be subject to the same scientific review by the Grants Working Group as a Grant application, and final determination of scientific merit by the ICOC.
Scientific Review. In conjunction with the SAC, Dr. ▇▇▇ ▇▇▇▇ ▇▇▇ll review scientific and clinical data on compounds acquired by Ilex Oncology. As co-chairman of the SAC, Dr. ▇▇▇ ▇▇▇▇ ▇▇▇ll report to the management of Ilex Oncology the results of the SAC findings and recommendations relative to such compounds.
Scientific Review. If the outside protocol is funded by an NIH grant or contract, there is no need to address scientific review. Otherwise, OHSRP will forward information to the CD about what scientific review, if any, occurred, and the CD will decide if it is adequate.
Scientific Review. In conjunction with the SAB, Dr. ▇▇▇ ▇▇▇▇ ▇▇▇ll review scientific and clinical data on compounds acquired by ILEX. As co-chairman of the SAB, Dr. ▇▇▇ ▇▇▇▇ ▇▇▇ll report to the management of ILEX the results of the SAB findings and recommendations relative to such compounds.
Scientific Review. The Partners intend for the activities carried out in support of this MOU to be reviewed at regular intervals by their respective institutional review groups. For NCATS/DPI, NIEHS/DNTP, and EPA/ORD, the reviews will be conducted by their respective Board of Scientific Counselors, and for FDA, by the FDA Agency Toxicology Working Group, and the Science Board to the Food and Drug Administration.
Scientific Review. Draft results may be presented in a scientific seminar or conference to ▇▇▇▇▇▇ technical, scientific peer review comments. If that occurs, a copy of the information to be presented may be provided to County Representative in advance of the presentation.